Dubai Final-v20.indd - World Allergy Organization

More documents

Recommendations

Info

POstErs POstErs WAO IntErnAtIOnAl ScIEntIfIc cOnfErEncE Asthma and Co-morbid Conditions: Expanding the Practice of Allergy for Optimal Patient Care 2312 oPEn-laBEl USE oF nanoFilTErED C1 ESTEraSE inHiBiTor (HUman) For TrEaTmEnT or ProPHYlaXiS oF aCUTE aTTaCKS oF HErEDiTarY angioEDEma (HaE) in PrEgnanT SUBJECTS J. Baker 1 , m. riedl 2 , A. Banerji 3 , D. Hurewitz 4 , r. levy 5 , t. J. Craig, DO 6 , i. Kalfus 7 , C. Broom 8 , s. Villano 8 , m. Uknis 8 , g. tillotson 8 and t. Cinryze study group 9 1 University of Michigan, Ann Arbor, MI. 2 UCLA Medical Center, Los Angeles, CA. 3 Massachusetts General Hospital, Boston, MA. 4 Allergy Clinic of Tulsa, Inc., Tulsa, OK. 5 Family Allergy and Asthma Center, PC, Atlanta, GA. 6 Penn State University, Hershey, PA. 7 Lev Pharmaceuticals, Plymouth Meeting, PA. 8 ViroPharma Incorporated, Exton, PA. www.worldallergy.org 70 FinAl PrOgrAm
POstErs WAO IntErnAtIOnAl ScIEntIfIc cOnfErEncE Asthma and Co-morbid Conditions: Expanding the Practice of Allergy for Optimal Patient Care Wednesday, 8 December 2010 – Poster Session 3 9:30 – 10:30 PO3-1: immune mechanisms of allergy sheikh rashid F To view full abstracts from this session, please reference pages 139-145 of the ‘Abstracts’ section in this program. Chairpersons: robert lemanske Jung Wong Park 3100 an UnUSUal PrESEnTaTion oF PUlmonarY maSS liKE lESionS SEConDarY To an allErgiC CaUSE m. rafique, Pulmonologist and B. mahboub, Head, of, Pulmonary, medicine Department of Pulmonary Medicine, Rashid Hospital, Dubai, United Arab Emirates. 3101 ForgoTTEn ParaSiTES in allErgY PraCTiCE P. Kumar, mD Medicine, Louisiana State University Health Sciences Center, New Orleans, LA. 3102 CHaraCTEriSTiCS oF rHinoVirUS-inDUCED PBmC immUnE rESPonSES in aSTHmaTiCS, From inFanCY To aDUlTHooD i. Katsuhito 1 , t. Katsunuma 1 , H. saito, mD, PhD, Director 2 and K. matsumoto, mD, PhD, laboratory, Head 2 1 Pediatrics, Jikei University, school of medicine, Tokyo, Japan. 2 Laboratory for allergy, Department of Allergy and Immunology, National Research Institute for Child Health and Development, Tokyo, Japan, Tokyo, Japan. 3103 CUrCUmin maY inHiBiTS T CEll aCTiVaTion THroUgH STorE-oPEraTED Ca2+ EnTrY CHannElS anD K+ CHannElS W. K. Kim, Doctor1 and J. H. nam2 1 2 Asthma & Allergy, Dongguk University Ilsan Hospital, Goyang, South Korea. Physiology, Dongguk University collage of medicine, Kyung Ju, South Korea. 3104 nano-SiZED WElDing FUmE inCrEaSES inFlammaTorY CYToKinES, aPoPToSiS anD g2 arrEST in HUman T CEll linE Y. m. Chiung 1 , P. s. liu 2 , Y. Y. Chen 2 , J. B. lin 1 and C. J. tsai 3 1 Division of Medicine, Institute of Occupational Safety & Health, Taipei County, Taiwan. 2 Department of Microbiology, Soochow University, Taipei, Taiwan. 3 Institute of Environmental Engineering, National Chiao Tung University, Hsinchu. 3105 THE EFFiCaCY oF a naSal anTiHiSTaminE oloPaTaDinE For THE TrEaTmEnT oF SEroUS oTiTiS mEDia in CHilDrEn s. nsouli, m, D. Asthma and Allergy, DANVILLE ASTHMA AND ALLERGY CLINIC, DANVILLE, CALIFORNIA, USA, Danville, CA. 3106 ComBinaTion oF a naSal anTiHiSTaminE oloPaTaDinE anD a naSal CorTiCoSTEroiD, momETaSonE For THE TrEaTmEnT oF SEaSonal allErgiC rHiniTiS PaTiEnTS noT CUrrEnTlY ConTrollED on monoTHEraPY inTranaSal anTiHiSTaminE or inTranaSal CorTiCoSTEroiD s. nsouli, mD, AnD, sEniOr, CliniCAl, rEsEArCH, AssOCiAtE Asthma and Allergy, DANVILLE ASTHMA AND ALLERGY CLINIC, CALIFORNIA, USA, Danville, CA. 3107 EXPErimEnTallY UnraVEling THE aToPiC marCH m. s. Wilson, PhD Molecular Immunology, NIMR, MRC, London, United Kingdom. 3108 a noVEl rolE For THE ComPlEmEnT rEgUlaTor CD46 in EPiTHElial TigHT JUnCTion FormaTion/rEgUlaTion s. t. Al-shouli1 and C. Kemper2 1 2 Clinical Immunology and Allergy., King’s College London Guy’s and S’t Thomas’ Hospital, London, United Kingdom. MRC Centre for Transplantation, London, United Kingdom. www.worldallergy.org 71 FinAl PrOgrAm POstErs
Page 1 and 2:
Final Program 5-8 December 2010 •
Page 3 and 4:
CO COImportant Dates 30 June 2011 E
Page 5 and 6:
WAO IntErnAtIOnAl ScIEntIfIc cOnfEr
Page 7 and 8:
ABOUt WAO the World Allergy Organiz
Page 9:
WAO mEmBEr sOCiEtiEs Albanian socie
Page 12 and 13:
gEnErAl inFOrmAtiOn, A-Z BAnKs/Atm
Page 14 and 15:
ONBREZ ® BREEZHALER ® Important n
Page 16 and 17:
COnFErEnCE inFOrmAtiOn, A-Z DisClAi
Page 18 and 19:
COnFErEnCE inFOrmAtiOn, A-Z sPEAKEr
Page 20 and 21:
Helping to control asthma throughou
Page 22 and 23: OPtiOnAl tOUrs CitY OF COntrAsts -
Page 24 and 25: EXHiBitiOn FlOOrPlAn sHEiKH rAsHiD
Page 26 and 27: EXHiBitOr DirECtOrY EaaCi - Europea
Page 28: EXHiBitOr DirECtOrY omron Healthcar
Page 32 and 33: WAO IntErnAtIOnAl ScIEntIfIc cOnfEr
Page 34 and 35: PrOgrAm-At-A-glAnCE registration Ou
Page 36 and 37: sUnDAY, 5 DECEmBEr 2010 WAO IntErnA
Page 38 and 39: sUnDAY, 5 DECEmBEr 2010 WAO IntErnA
Page 40 and 41: mOnDAY, 6 DECEmBEr 2010 WAO IntErnA
Page 46 and 47: tUEsDAY, 7 DECEmBEr 2010 WAO IntErn
Page 52 and 53: WEDnEsDAY, 8 DECEmBEr 2010 WAO IntE
Page 54 and 55: WEDnEsDAY, 8 DECEmBEr 2010 WAO IntE
Page 56 and 57: POstErs POstErs WAO IntErnAtIOnAl S
Page 78: POstErs POstErs WAO IntErnAtIOnAl S
Page 81 and 82: ABstrACts results: the prevalence o
Page 83 and 84: ABstrACts effective diagnosis and e
Page 85 and 86: ABstrACts mWCnts on OVA-asthma mode
Page 87 and 88: ABstrACts allergy in human. A Burka
Page 89 and 90: ABstrACts Patients with all negativ
Page 91 and 92: ABstrACts both gender, suggesting a
Page 93 and 94: ABstrACts 1208 THE rolE oF inTErlEU
Page 95 and 96: ABstrACts of oral steroids in last
Page 97 and 98: ABstrACts 1215 aSTHma ComPliCaTion
Page 99 and 100: ABstrACts to allergens, lower sever
Page 101 and 102: ABstrACts 1301 non-EoSinoPHiliC aST
Page 103 and 104: ABstrACts participated in this stud
Page 105 and 106: ABstrACts for attacks of shortness
Page 107 and 108: ABstrACts blood CD4+ t cells expres
Page 109 and 110: ABstrACts Conclusion Air pollution
Page 111 and 112: ABstrACts 1322 EPiTHElial CEll DEri
Page 113 and 114: ABstrACts 1326 analYSiS oF gEnE EXP
Page 115 and 116: ABstrACts rhinitis patients in Hosp
Page 117 and 118: ABstrACts selected adults from the
Page 119 and 120: ABstrACts nasal Olopatadine led to
Page 121 and 122: ABstrACts therapy. However, patient
Page 123 and 124:
ABstrACts that when Ds within the s
Page 125 and 126:
ABstrACts result the patient was di
Page 127 and 128:
ABstrACts 2203 FooD allErgY anD aTo
Page 129 and 130:
ABstrACts 1.11+/- 0.81 for type i a
Page 131 and 132:
ABstrACts 2212 aSSESSing PoTEnTial
Page 133 and 134:
ABstrACts regular treatment with be
Page 135 and 136:
ABstrACts 2301 EFFECT oF a SYnBioTi
Page 137 and 138:
ABstrACts C3 (50 mg/dl; normal 90 -
Page 139 and 140:
ABstrACts introduction : HAE is a g
Page 141 and 142:
ABstrACts PoSTEr SESSion 3-1: immun
Page 143 and 144:
ABstrACts smaller than 100 nm. Cell
Page 145 and 146:
ABstrACts and dry weather city of A
Page 147 and 148:
ABstrACts 3114 igg4 aS THE PrEDomin
Page 149 and 150:
ABstrACts Conclusion: Our study dem
Page 151 and 152:
ABstrACts abscesses are visible at
Page 153 and 154:
ABstrACts allergen release (depot e
Page 155 and 156:
ABstrACts COnClUsiOns: Empiric trea
Page 157 and 158:
ABstrACts Conclusion:sPlAD and FPig
Page 159 and 160:
ABstrACts autumn only in 13% of cas
Page 161 and 162:
ABstrACts mEtHODs: ninety-six child
Page 163 and 164:
ABstrACts 3321 aSSoCiaTion BETWEEn
Page 165 and 166:
sPEAKEr AnD CHAirPErsOn inDEX last
Page 167 and 168:
POstEr AUtHOr inDEX WAO IntErnAtIOn
Page 169 and 170:
Page 171 and 172:
Page 173 and 174:
nOtEs WAO IntErnAtIOnAl ScIEntIfIc
Page 175 and 176:
Q411-10 Allergic disease is a growi
Page 177:
2010 WAO IntErnAtIOnAl ScIEntIfIc c
show all

Dubai Final-v20.indd - World Allergy Organization

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?